Anebulo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 18 shareholders own 92.4% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
46.3%	Joseph Lawler	12,000,000	US$25.8m	0%	no data
20.7%	22NW, LP	5,366,290	US$11.5m	0%	8.58%
18%	Aron English	4,654,528	US$10.0m	0%	no data
2.48%	LVW Advisors, LLC	642,039	US$1.4m	-0.16%	0.25%
1.97%	Nantahala Capital Management, LLC	511,073	US$1.1m	0%	0.12%
1.54%	Morgan Stanley, Investment Banking and Brokerage Investments	399,219	US$858.3k	0%	no data
0.61%	Ikarian Capital, LLC	157,862	US$339.4k	0%	0.11%
0.59%	The Vanguard Group, Inc.	153,472	US$330.0k	0.31%	no data
0.097%	Susquehanna International Group, LLP, Asset Management Arm	25,253	US$54.3k	0%	no data
0.088%	Geode Capital Management, LLC	22,777	US$49.0k	247%	no data
0.073%	Boothbay Fund Management, LLC	18,978	US$40.8k	0%	no data
0.02%	Tower Research Capital LLC	5,138	US$11.0k	-43.6%	no data
0.016%	BlackRock, Inc.	4,049	US$8.7k	-2.32%	no data
0.0014%	Lord, Abbett & Co. LLC	366	US$786.2	0%	no data
0.00056%	UBS Asset Management AG	144	US$312.2	0%	no data
0.00024%	Wells Fargo & Company, Private Banking and Investment Banking Arm	62	US$133.8	1.64%	no data
0.00015%	Royal Bank of Canada, Banking & Securities Investments	38	US$83.6	-46.5%	no data
0.00003%	JPMorgan Chase & Co, Brokerage and Securities Investments	9	US$16.7	0%	no data